{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:44:40Z","timestamp":1785465880893,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1587,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood transfusion Research","doi-asserted-by":"publisher","award":["1504"],"award-info":[{"award-number":["1504"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1111\/jth.14140","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T18:38:38Z","timestamp":1525718318000},"page":"1357-1368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Correction of a dominant\u2010negative von Willebrand factor multimerization defect by small interfering RNA\u2010mediated allele\u2010specific inhibition of mutant von Willebrand factor"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-535X","authenticated-orcid":false,"given":"A.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Oud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J. M","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-5759","authenticated-orcid":false,"given":"J.","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14140_bb0010","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14140_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"10.1111\/jth.14140_bb0020","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14140_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","article-title":"Treatment of von Willebrand disease","volume":"42","author":"Curnow","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14140_bb0030","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"1\u2010Deamino\u20108\u2010d\u2010arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands\u2019 diseases","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/jth.14140_bb0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/17474086.2016.1214070","article-title":"Von Willebrand factor (Vonvendi(R)): the first recombinant product licensed for the treatment of von Willebrand disease","volume":"9","author":"Franchini","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1111\/jth.14140_bb0040","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2013-06-498303","article-title":"Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","volume":"122","author":"von Lillicrap","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0045","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2010-02-268920","article-title":"The dominant\u2010negative von Willebrand factor gene deletion p. P1127_C1948delinsR: molecular mechanism and modulation","volume":"116","author":"Casari","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2017.09.025","article-title":"Von Willebrand disease mutation spectrum and associated mutation mechanisms","volume":"159","author":"de Jong","year":"2017","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14140_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1111\/jth.14140_bb0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.ATV.0000069847.72001.E8","article-title":"Real\u2010time imaging of the dynamics and secretory behavior of Weibel\u2013Palade bodies","volume":"23","author":"Romani de Wit","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14140_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2144\/05391RV01","article-title":"Real\u2010time PCR for mRNA quantitation","volume":"39","author":"Wong","year":"2005","journal-title":"Biotechniques"},{"key":"10.1111\/jth.14140_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14140_bb0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.5551\/jat.30809","article-title":"Unexpectedly high prevalence of acquired von Willebrand syndrome in patients with severe aortic stenosis as evaluated with a novel large multimer index","volume":"22","author":"Tamura","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1111\/jth.14140_bb0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1160\/TH06-08-0460","article-title":"Differential effects of the loss of intrachain\u2010 versus interchain\u2010disulfide bonds in the cystine\u2010knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease","volume":"96","author":"Tjernberg","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14140_bb0085","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/mtna.2016.7","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington's disease","volume":"5","author":"Miniarikova","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1111\/jth.14140_bb0090","doi-asserted-by":"crossref","first-page":"e2227","DOI":"10.1038\/cddis.2016.118","article-title":"Allele\u2010specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity","volume":"7","author":"Novelli","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1111\/jth.14140_bb0095","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele\u2010specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14140_bb0100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three\u2010quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"10.1111\/jth.14140_bb0105","doi-asserted-by":"crossref","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele\u2010specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14140_bb0110","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele\u2010specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol Ther"},{"key":"10.1111\/jth.14140_bb0115","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1038\/ncomms5240","article-title":"Allele\u2010specific genome editing and correction of disease\u2010associated phenotypes in rats using the CRISPR\u2010Cas platform","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/jth.14140_bb0120","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/nprot.2012.093","article-title":"Establishment of outgrowth endothelial cells from peripheral blood","volume":"7","author":"Martin\u2010Ramirez","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1111\/jth.14140_bb0125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2015-10-678052","article-title":"Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism","volume":"128","author":"Hawke","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0130","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0135","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MBC.0000000000000635","article-title":"Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients","volume":"28","author":"Selvam","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14140_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.2830330113","article-title":"Postoperative thrombocytopenia in type IIB von Willebrand disease","volume":"33","author":"Hultin","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14140_bb0150","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V69.3.786.786","article-title":"Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease","volume":"69","author":"Rick","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0155","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/jth.13112","article-title":"Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease","volume":"13","author":"Groeneveld","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14140_bb0160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14140_bb0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2\u2010year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/jth.14140_bb0170","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.thromres.2006.01.022","article-title":"Gastrointestinal bleeding in von Willebrand disease","volume":"118","author":"Makris","year":"2006","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14140_bb0175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1616569","article-title":"Targeting of antithrombin in hemophilia A or B with RNAi therapy","volume":"377","author":"Pasi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14140_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12959-017-0130-8","article-title":"Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy","volume":"15","author":"Heestermans","year":"2017","journal-title":"Thromb J"},{"key":"10.1111\/jth.14140_bb0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat Nanotechnol"},{"key":"10.1111\/jth.14140_bb0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/mt.2013.291","article-title":"Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC","volume":"22","author":"Fehring","year":"2014","journal-title":"Mol Ther"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622023297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622023297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14140\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:20:52Z","timestamp":1761535252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622023297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1538783622023297"],"URL":"https:\/\/doi.org\/10.1111\/jth.14140","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction of a dominant\u2010negative von Willebrand factor multimerization defect by small interfering RNA\u2010mediated allele\u2010specific inhibition of mutant von Willebrand factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}